Deptor transcriptionally regulates endoplasmic reticulum homeostasis in multiple myeloma cells

Valeria Catena1, Tiziana Bruno1, Francesca De Nicola1

  • 1SAFU, Department of Research, Advanced Diagnostics, and Technological Innovation, Translational Research Area, Regina Elena National Cancer Institute, 00144, Rome, Italy.

Oncotarget
|September 23, 2016
PubMed

Insights

Deptor, a protein overexpressed in multiple myeloma (MM), acts as a nuclear factor regulating endoplasmic reticulum (ER) homeostasis. Its depletion exacerbates ER stress and enhances bortezomib treatment efficacy in MM cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Biology

Background:

  • Multiple myeloma (MM) involves malignant plasma cells with high immunoglobulin production, leading to endoplasmic reticulum (ER) stress.
  • Deptor, an mTOR-binding protein, is overexpressed in MM, inhibiting mTOR kinase and promoting survival via Akt signaling.

Purpose of the Study:

  • To investigate the role of Deptor in multiple myeloma cell survival and ER homeostasis.
  • To identify Deptor as a nuclear protein involved in regulating gene transcription related to ER function.

Main Methods:

  • Identification of Deptor's subcellular localization (nuclear).
  • Assessment of Deptor's DNA-binding and transcriptional regulatory capabilities.
  • Analysis of Deptor's role in maintaining ER network and gene expression.
  • Evaluation of Deptor depletion effects on ER stress and bortezomib sensitivity.

Main Results:

  • Deptor is identified as a nuclear protein that binds DNA and regulates transcription in MM cells.
  • Deptor is crucial for maintaining the ER network by sustaining the expression of key ER-related genes.
  • Deptor depletion induces significant ER stress in MM cells.
  • Depletion of Deptor synergizes with bortezomib, enhancing its anti-myeloma effect.

Conclusions:

  • Deptor plays a critical role in maintaining ER homeostasis in multiple myeloma cells.
  • Targeting Deptor may represent a novel therapeutic strategy to overcome bortezomib resistance in MM.
  • These findings offer new insights into ER stress control mechanisms in multiple myeloma.